Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Feb 6, 2024
- Accession no.
- 0000950170-24-011880
- Filed
- Feb 6, 2024
- Trade date
- Feb 2-6, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.51M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | MOption exerciseAcquired | +25,393 | $0.61 | +$15,489.73 | 553,374 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −73,093 | $16.31F2 | −$1,192,146.83 | 480,281 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −2,300 | $17.04F3 | −$39,192 | 477,981 | Direct | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −15,413 | $18.09F4 | −$278,821.17 | 462,568 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock | MOption exerciseDisposed | −25,393 | $0.00 | $0 | 108,110 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.91. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.17. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $18.00 to $18.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.